{"url_path":"/sec/ofix/8-k/2026-06-11/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-11","source_url":"https://www.sec.gov/Archives/edgar/data/884624/0001193125-26-266679-index.html","accession_number":"0001193125-26-266679","cik":"0000884624","ticker":"OFIX","issuer_name":"Orthofix Medical Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/884624/0001193125-26-266679-index.html","primary_entity_key":"0000884624","primary_entity_name":"Orthofix Medical Inc."},"word_count":88,"has_tables":true,"body_markdown":"## Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits\n\nExhibit No.\n\nDescription\n\n10.1\n\n[Amendment No. 5 to the Orthofix Medical Inc. Second Amended and Restated Stock Purchase Plan](ofix-ex10_1.htm)\n\n104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\nOrthofix Medical Inc.\n\n \n\n \n\n \n\n \n\nDate:\n\nJune 11, 2026\n\nBy:\n\n/s/ J. Andrés Cedrón\n\n \n\n \n\n \n\nJ. Andrés Cedrón\nChief Legal Officer"}